Tarantula toxins interacting with voltage sensors in potassium channels.

Molecular Physiology and Biophysics Section, Porter Neuroscience Research Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Toxicon (Impact Factor: 2.92). 03/2007; 49(2):213-30. DOI: 10.1016/j.toxicon.2006.09.024
Source: PubMed

ABSTRACT Voltage-activated ion channels open and close in response to changes in membrane voltage, a process that is crucial for electrical signaling in the nervous system. The venom from many poisonous creatures contains a diverse array of small protein toxins that bind to voltage-activated channels and modify the gating mechanism. Hanatoxin and a growing number of related tarantula toxins have been shown to inhibit activation of voltage-activated potassium (K(v)) channels by interacting with their voltage-sensing domains. This review summarizes our current understanding of the mechanism by which these toxins alter gating, the location of the toxin receptor within K(v) channels and the disposition of this receptor with respect to the lipid membrane. The conservation of tarantula toxin receptors among voltage-activated ion channels will also be discussed.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Potassium channels participate in many critical biological functions and play important roles in a variety of diseases. In recent years, many significant discoveries have been made which motivate us to review these achievements. The focus of our review is mainly on three aspects. Firstly, we try to summarize the latest developments in structure determinants and regulation mechanism of all types of potassium channels. Secondly, we review some diseases induced by or related to these channels. Thirdly, both qualitative and quantitative approaches are utilized to analyze structural features of modulators of potassium channels. Our analyses further prove that modulators possess some certain natural product scaffolds. And pharmacokinetics parameters are important properties for organic molecules. Besides, with in silico methods, some features which can be used to differentiate modulators are derived. There is no doubt that all these studies on potassium channels as possible pharmaceutical targets will facilitate future translational research. All the strategies developed in this review could be extended to studies on other ion channels and proteins as well. This article is protected by copyright. All rights reserved.
    Chemical Biology &amp Drug Design 10/2013; · 2.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Connexins form gap junctions that function as intercellular channels and hemichannels that form a conduit between the cytoplasm and extracellular fluid when open. Peptide inhibitors of connexin channels, especially those identical to defined connexin sequences, are interesting experimental, and possibly also therapeutic tools because they may have better selectivity than general inhibitors like carbenoxolone. Over the past ten years, several peptides have been demonstrated to block hemichannels, including Gap26, Gap27, peptide5, L2 and Gap19; some of these specifically block hemichannels but not gap junctions. Most of these peptides have only recently been investigated towards their actions at the single hemichannel level, bringing up interesting information on how they interact with the connexin protein and how they affect hemichannel gating. Hemichannels can be opened by electrical, mechanical and chemical stimuli. We here review the effect of the prototypic peptides Gap26/27 and L2/Gap19 with specific focus on their inhibition of Cx43 hemichannel opening triggered by positive membrane potentials and changes in intracellular Ca(2+) concentration. Both Gap26/27 and L2/Gap19 peptide families block Cx43 hemichannel opening triggered by voltage as well as intracellular Ca(2+) stimulation. Interestingly, these peptides as well as intracellular Ca(2+) elevation modulate the voltage activation threshold for hemichannel opening, pointing to a common target. Moreover, L2 and Gap19 peptides are part of a sequence on the cytoplasmic loop that acts as a Ca(2+)/calmodulin interaction site. We here review the interesting network of interactions between Cx43 targeting peptides, voltage gating and intracellular Ca(2+) as major modulators of hemichannel function.
    Neuropharmacology 09/2013; · 4.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Scolopendra subspinipes mutilans, also known as Chinese red-headed centipede, is a venomous centipede from East Asia and Australasia. Venom from this animal has not been researched as thoroughly as venom from snakes, snails, scorpions, and spiders. In this study, we isolated and characterized SsmTx-I, a novel neurotoxin from the venom of S. subspinipes mutilans. SsmTx-I contains 36 residues with four cysteines forming two disulfide bonds. It had low sequence similarity (<10%) with other identified peptide toxins. By whole-cell recording, SsmTx-I significantly blocked voltage-gated K(+) channels in dorsal root ganglion neurons with an IC50 value of 200 nM, but it had no effect on voltage-gated Na(+) channels. Among the nine K(+) channel subtypes expressed in human embryonic kidney 293 cells, SsmTx-I selectively blocked the Kv2.1 current with an IC50 value of 41.7 nM, but it had little effect on currents mediated by other K(+) channel subtypes. Blockage of Kv2.1 by SsmTx-I was not associated with significant alteration of steady-state activation, suggesting that SsmTx-I might act as a simple inhibitor or channel blocker rather than a gating modifier. Our study reported a specific Kv2.1-blocker from centipede venom and provided a basis for future investigations of SsmTx-I, for example on structure-function relationships, mechanism of action, and pharmacological potential. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.
    Journal of Peptide Science 01/2014; · 2.07 Impact Factor


Available from